Currently out of the existing stock ratings of Jason Gerberry, 191 are a BUY (65.86%), 66 are a HOLD (22.76%), 33 are a SELL (11.38%).

Jason Gerberry

Work Performance Price Targets & Ratings Chart

Analyst Jason Gerberry, currently employed at BAML, carries an average stock price target met ratio of 61.75% that have a potential upside of 27.72% achieved within 287 days.

Jason Gerberry’s has documented 603 price targets and ratings displayed on 59 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on HRMY, Harmony Biosciences Holdings at 25-Feb-2026.

Wall Street Analyst Jason Gerberry

Analyst best performing recommendations are on PROK (PROKIDNEY CORP.).
The best stock recommendation documented was for PROK (PROKIDNEY CORP.) at 6/30/2025. The price target of $1 was fulfilled within 8 days with a profit of $0.41 (69.49%) receiving and performance score of 86.86.

Average potential price target upside

of $87.71 (57.13%) on FWP (FORWARD PHARMA A S).
of $62.11 (34.32%) on KRTX (KARUNA THERAPEUTICS).
of $54.25 (34.91%) on FGEN (FIBROGEN).

ABBV AbbVie AGN Allergan plc ALKS Alkermes Plc BHC Bausch Health Companies BLUE Bluebird bio BYSI BeyondSpring ENDP Endo International PLC FGEN FibroGen GLPG Galapagos NV ADR HZNP Horizon Pharma PLC IONS Ionis Pharmaceuticals JAZZ Jazz Pharmaceuticals PLC LLY Eli Lilly and Company MNK Mallinckrodt plc MRK Merck mpany MRTX Mirati Ther MYL Viatris PCVX Vaxcyte TARS Tarsus Pharmaceuticals TEVA Teva Pharma Industries Ltd ADR ALLO Allogene Therapeutics BMY Bristol-Myers Squibb Company HRTX Heron Therapeuti MNTA Momenta Pharmaceuticals PFE Pfizer AKRX Akorn ARNA Arena Pharmaceuticals AVDL Avadel Pharmaceuticals PLC CORI Corium International KRTX Karuna Therapeutics PRGO Perrigo Company PLC DICE Dice Molecules Holdings LLC FWP Forward Pharma A S VTRS Viatris OGN Organon ACLX Arcellx AERI Aerie Pharmaceuticals AMTI Applied Molecular Transport CARA Cara Therapeutic LYRA Lyra Therapeutics CHRS Coherus BioSciences RLAY Relay Therapeutics XENE Xenon Pharmaceuticals AXSM Axsome Therapeutics ARWR Arrowhead Pharmaceuticals HRMY Harmony Biosciences Holdings ITCI Intracellular Th AMPH Amphastar P CPRX Catalyst Pharmaceuticals EXEL Exelixis IMVT Immunovant OCS Oculis Holding AG Ordinary shares PROK ProKidney Corp. BHVN Biohaven Pharmaceutical Holding Co Ltd KALV Kalvista Pharmaceuticals NBRV Nabriva Therapeutics AG SESN Sesen Bio VRCA Verrica Pharmaceuticals ASRT Assertio Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Trung Huynh (UBS)